(Q50575004)

15 March 2018

title

Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. (English)

1 reference

15 March 2018

0 references

1 reference

10

Fung JJ

1 reference

15 March 2018

8

Demetris A

1 reference

15 March 2018

de Vera ME

1

1 reference

15 March 2018

Dvorchik I

2

1 reference

15 March 2018

Tom K

3

1 reference

15 March 2018

Eghtesad B

4

1 reference

15 March 2018

Thai N

5

1 reference

15 March 2018

Shakil O

6

1 reference

15 March 2018

Marcos A

7

1 reference

15 March 2018

Jain A

9

1 reference

15 March 2018

Ragni MV

11

1 reference

15 March 2018

language of work or name

English

0 references

publication date

1 December 2006

1 reference

15 March 2018

American Journal of Transplantation

published in

1 reference

15 March 2018

volume

6

1 reference

15 March 2018

issue

12

1 reference

15 March 2018

page(s)

2983-2993

1 reference

15 March 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Survival of Human Immunodeficiency Virus–Infected Liver Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Liver transplantation in adults coinfected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Tolerogenic immunosuppression for organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Transplantation in HIV+ patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Management of hepatitis C virus infection in the setting of liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

The association between hepatitis C infection and survival after orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Is retransplantation an option for recurrent hepatitis C cirrhosis after liver transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Impact of immunosuppressive therapy on recurrence of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Long-term outcome of hepatitis C infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Long-term outcome of hepatitis C virus infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

Management of hepatitis C in liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01546.X

10.1111/J.1600-6143.2006.01546.X

21 January 2018

Identifiers

DOI

1 reference

15 March 2018

PubMed ID

17062005

1 reference

15 March 2018